Benzinga | Jan 12, 2021 05:05AM EST

Timber Pharmaceuticals Received FDA Orphan Drug Designation on Monday for Sitaxentan for Treatment of Systemic Sclerosis

https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=793420